425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
8-K: Current report
10-Q: Q2 2024 Earnings Report
425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
8-K: Current report
D: Filing D
425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
8-K: Current report
EFFECT: Others
424B3: Prospectus
CORRESP: CORRESP
UPLOAD: Others
S-1: General form for registration of securities under the Securities Act of 1933
10-K/A: Annual report (Amendment)
10-Q: Q1 2024 Earnings Report
NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
10-K: FY2023 Annual Report
HEPION PHARMACEUTICALS INC PREFERRED STOCK | NT 10-K: Others
No Data
No Data